LUYE PHARMA Successfully Completes Early Redemption of Outstanding US$180 Million Convertible Notes Due 2028

Stock News07-06

LUYE PHARMA (ASX: 02186) has announced the completion of the early redemption of all its outstanding convertible bonds.

The company had received redemption notices, requiring it to redeem the full outstanding principal amount of US$90.26 million, plus any accrued but unpaid interest up to the selective put date of July 6, 2026, as per the bond terms.

As of the announcement date, the early redemption process has been finalized, with all outstanding bonds redeemed and cancelled, leaving no bonds outstanding.

Consequently, the company has applied to The Stock Exchange of Hong Kong Limited for the withdrawal of the listing of these bonds.

The delisting is expected to take effect after business hours on July 15, 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment